237 related articles for article (PubMed ID: 22812676)
1. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer.
Kim HJ; Kim NK; Choi JH; Sohn SY; Kim SW; Jin SM; Jang HW; Suh S; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Jan; 78(1):134-40. PubMed ID: 22812676
[TBL] [Abstract][Full Text] [Related]
2. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713
[TBL] [Abstract][Full Text] [Related]
3. Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study.
Wu C; Wang L; Chen W; Zou S; Yang A
Medicine (Baltimore); 2017 Mar; 96(9):e6202. PubMed ID: 28248875
[TBL] [Abstract][Full Text] [Related]
4. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.
Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F
Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452
[TBL] [Abstract][Full Text] [Related]
5. Obesity and High Risk Pathological Features of Papillary Thyroid Carcinoma: A Retrospective Analysis of a University Hospital in Pakistan.
Zaman SU; Awan MS; Sulaiman MA
Gulf J Oncolog; 2018 May; 1(27):6-10. PubMed ID: 30145545
[TBL] [Abstract][Full Text] [Related]
6. Association of Body Mass Index With Clinicopathological Features of Papillary Thyroid Carcinoma: A Retrospective Study.
Dong Z; Liu W; Su F; Cheng R
Endocr Pract; 2023 Feb; 29(2):83-88. PubMed ID: 36481471
[TBL] [Abstract][Full Text] [Related]
7. Is body mass index relevant to prognosis of papillary thyroid carcinoma? A clinicopathological cohort study.
Chung YS; Lee JH; Lee YD
Surg Today; 2017 Apr; 47(4):506-512. PubMed ID: 27654453
[TBL] [Abstract][Full Text] [Related]
8. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.
Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH
J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652
[TBL] [Abstract][Full Text] [Related]
9. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
[TBL] [Abstract][Full Text] [Related]
10. Association Between Aggressive Clinicopathologic Features of Papillary Thyroid Carcinoma and Body Mass Index: A Systematic Review and Meta-Analysis.
Economides A; Giannakou K; Mamais I; Economides PA; Papageorgis P
Front Endocrinol (Lausanne); 2021; 12():692879. PubMed ID: 34276564
[TBL] [Abstract][Full Text] [Related]
11. Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma.
Choi JS; Kim EK; Moon HJ; Kwak JY
Endocrine; 2015 Feb; 48(1):264-71. PubMed ID: 24858734
[TBL] [Abstract][Full Text] [Related]
12. High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma.
Li WF; Wang G; Zhao ZB; Liu CA
Clin Endocrinol (Oxf); 2015 Oct; 83(4):572-80. PubMed ID: 25418110
[TBL] [Abstract][Full Text] [Related]
13. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
14. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
Gąsior-Perczak D; Pałyga I; Szymonek M; Kowalik A; Walczyk A; Kopczyński J; Lizis-Kolus K; Trybek T; Mikina E; Szyska-Skrobot D; Gadawska-Juszczyk K; Hurej S; Szczodry A; Słuszniak A; Słuszniak J; Mężyk R; Góźdź S; Kowalska A
PLoS One; 2018; 13(10):e0204668. PubMed ID: 30273371
[TBL] [Abstract][Full Text] [Related]
15. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors.
Li CL; Dionigi G; Zhao YS; Liang N; Sun H
J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701
[TBL] [Abstract][Full Text] [Related]
16. Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma.
Liu Z; Maimaiti Y; Yu P; Xiong Y; Zeng W; Li X; Song H; Lu C; Xin Y; Zhou J; Zhang N; Ming J; Liu C; Shi W; Shi L; Li X; Nie X; Huang T
Int J Clin Exp Med; 2015; 8(9):16472-9. PubMed ID: 26629173
[TBL] [Abstract][Full Text] [Related]
17. Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma.
Kim SK; Woo JW; Park I; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2016 May; 26(5):657-66. PubMed ID: 26959390
[TBL] [Abstract][Full Text] [Related]
18. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
[TBL] [Abstract][Full Text] [Related]
19. Association of Preoperative US Features and Recurrence in Patients with Classic Papillary Thyroid Carcinoma.
Kim SY; Kwak JY; Kim EK; Yoon JH; Moon HJ
Radiology; 2015 Nov; 277(2):574-83. PubMed ID: 25955580
[TBL] [Abstract][Full Text] [Related]
20. [Association between body mass index and aggressiveness of papillary thyroid carcinoma].
Faure EN; Soutelo MJ; Fritz MC; Martín A; Musri Y; Lutfi R
Medicina (B Aires); 2018; 78(3):145-150. PubMed ID: 29940539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
